Discovery of a Non-Peptidic Inhibitor of West Nile Virus NS3 Protease by High-Throughput Docking

被引:60
作者
Ekonomiuk, Dariusz [1 ]
Su, Xun-Cheng [2 ]
Ozawa, Kiyoshi [2 ]
Bodenreider, Christophe [3 ]
Lim, Siew Pheng [3 ]
Yin, Zheng [3 ]
Keller, Thomas H. [3 ]
Beer, David [3 ]
Patel, Viral [3 ]
Otting, Gottfried [2 ]
Caflisch, Amedeo [1 ]
Huang, Danzhi [1 ]
机构
[1] Univ Zurich, Dept Biochem, Zurich, Switzerland
[2] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia
[3] Novartis Inst Trop Dis, Chromos, Singapore
来源
PLOS NEGLECTED TROPICAL DISEASES | 2009年 / 3卷 / 01期
关键词
HEPATITIS-C-VIRUS; ORBITAL ELECTRONEGATIVITY METHOD; MODIFIED PARTIAL EQUALIZATION; SERINE-PROTEASE; ANTIVIRAL ACTIVITY; PEPTIDE INHIBITORS; INTERACTION ENERGIES; BETA-SECRETASE; BINDING; POTENT;
D O I
10.1371/journal.pntd.0000356
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The non-structural 3 protease (NS3pro) is an essential flaviviral enzyme and therefore one of the most promising targets for drug development against West Nile virus (WNV) and dengue infections. Methodology: In this work, a small-molecule inhibitor of the WNV NS3pro has been identified by automatic fragment-based docking of about 12000 compounds and testing by nuclear magnetic resonance (NMR) spectroscopy of only 22 molecules. Specific binding of the inhibitor into the active site of NS3pro and its binding mode are confirmed by N-15-HSQC NMR spectra. The inhibitory activity is further validated by an enzymatic assay and a tryptophan fluorescence quenching assay. Conclusion: The inhibitor [4-(carbamimidoylsulfanylmethyl)-2,5-dimethylphenyl]-methylsulfanylmethanimidamide has a good ratio of binding affinity versus molecular weight ( ligand efficiency of 0.33 kcal/mol per non-hydrogen atom), and thus has good potential as lead compound for further development to combat West Nile virus infections.
引用
收藏
页数:9
相关论文
共 67 条
  • [1] Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold
    Aleshin, Alexander E.
    Shiryaev, Sergey A.
    Strongin, Alex Y.
    Liddington, Robert C.
    [J]. PROTEIN SCIENCE, 2007, 16 (05) : 795 - 806
  • [2] Apostolakis J, 1999, COMB CHEM HIGH T SCR, V2, P91
  • [3] NEW METHOD FOR PREDICTING BINDING-AFFINITY IN COMPUTER-AIDED DRUG DESIGN
    AQVIST, J
    MEDINA, C
    SAMUELSSON, JE
    [J]. PROTEIN ENGINEERING, 1994, 7 (03): : 385 - 391
  • [4] Interaction energies between β-lactam antibiotics and E-coli penicillin-binding protein 5 by reversible thermal denaturation
    Beadle, BM
    Nicholas, RA
    Shoichet, BK
    [J]. PROTEIN SCIENCE, 2001, 10 (06) : 1254 - 1259
  • [5] BODENREIDER C, IDENTIFICATIFI UNPUB
  • [6] CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS
    BROOKS, BR
    BRUCCOLERI, RE
    OLAFSON, BD
    STATES, DJ
    SWAMINATHAN, S
    KARPLUS, M
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) : 187 - 217
  • [7] Fragment-based flexible ligand docking by evolutionary optimization
    Budin, N
    Majeux, N
    Caflisch, A
    [J]. BIOLOGICAL CHEMISTRY, 2001, 382 (09) : 1365 - 1372
  • [8] Caflisch A, 1997, J COMPUT CHEM, V18, P723, DOI 10.1002/(SICI)1096-987X(19970430)18:6<723::AID-JCC1>3.0.CO
  • [9] 2-U
  • [10] Automated docking of highly flexible ligands by genetic algorithms: A critical assessment
    Cecchini, M
    Kolb, P
    Majeux, N
    Caflisch, A
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 2004, 25 (03) : 412 - 422